Denali Therapeutics Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
DNLI on Nasdaq
Location
161 Oyster Point Blvd., South San Francisco, CA

Insiders trading volume in the past year

Denali Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert Nelsen Director $178M Jun 2, 2021
Ryan J. Watts President and CEO, Director $67.5M -$1.82M -2.63% Oct 18, 2024
Marc Tessier-Lavigne Director $43.2M May 31, 2024
E. Krognes Director $24.4M -$3.6M -12.8% Sep 30, 2024
Jay T. Flatley Director $7.07M May 31, 2024
Vicki L. Sato Director $3.33M -$449K -11.9% Nov 7, 2024
David P. Schenkein Director $1.33M -$1.93M -59.2% Nov 11, 2024
Alexander O. Schuth COFO and Secretary $491K -$1.31M -72.8% Nov 22, 2024
Douglas G. Cole Director $489K Jun 1, 2023
Peter S. Klein Director $438K May 31, 2024
Jennifer Cook Director $435K -$31.7K -6.78% Jun 6, 2024
Nancy Thornberry Director $381K May 31, 2024
Erik Harris Director $348K May 31, 2024
Carole Ho Chief Medical Officer $110K -$959K -89.7% Nov 25, 2024

Recent Insider Transactions by Companies or Individuals for Denali Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.